Clinical Trials Browser

Estrogen Receptor and/or Progesterone Receptor Positive × Pharmacogenomic Variants × Clear all

NCT03477396 2024-02-20

Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

Phase 2 Completed

2 enrolled 13 charts

Estrogen Receptor and/or Progesterone Receptor Positive